Probiotics (Lactobacillus).

Lactobacillus is unusual among gut bacteria in not needing iron to grow, which is part of how it holds its place in the colon. Because a high oral iron dose is only partly absorbed, the surplus that reaches the colon can feed iron-dependent bacteria and tilt the balance away from Lactobacillus, so it helps to space the two or keep an eye on the total iron load.

Inulin is a fructan fermented selectively by lactobacilli and bifidobacteria into short chain fatty acids. Pairing organism with substrate is the defining synbiotic combination.

Partially hydrolysed guar gum is a low-viscosity fermentable fibre that colonic bacteria convert to short chain fatty acids. It supplies fuel without the bulking load of whole guar.

Oat beta-glucan is fermented in the colon and shifts short chain fatty acid output. That fermentation is what supplemented organisms feed on.

Butyrate is the short chain fatty acid produced when colonic bacteria ferment fibre, and the main fuel of colonocytes. Supplying it delivers the output of that fermentation directly.

Lactobacilli carry beta-galactosidase, the same activity supplemental lactase supplies. Both act on lactose in the upper gut.

Psyllium holds water and is partly fermented, slowing transit and giving organisms more contact time and some fuel.

Carvacrol and thymol disrupt bacterial membranes indiscriminately, including the supplemented lactobacilli. Doses are separated so the organisms survive transit.

Charcoal adsorbs organic material broadly in the lumen and can bind bacterial cells and their substrate. Co-dosing lowers what is actually delivered.

Berberine has broad antibacterial activity and reshapes gut populations on its own. Taken together with lactobacilli it can reduce the viable count that arrives.

A number of lactobacilli synthesise folate in the gut, adding to dietary supply. Organism and vitamin sit on one supply route.

Galactooligosaccharides resist human digestion and are fermented by beta-galactosidase-carrying lactobacilli and bifidobacteria, which is the definition of a prebiotic substrate. Supplying the substrate alongside the organism is the reasoning behind synbiotic products. Fermentation gas is the practical trade-off at higher doses.

Short-chain fructans pass the small intestine intact and are fermented in the colon, favouring lactate and acetate producers. Pairing them with a Lactobacillus preparation gives the delivered organisms a carbon source. Fructans are also the substrate class most often implicated in bloating, so dose escalation matters.

Chicory inulin is a longer-chain fructan than FOS, so it is fermented further along the colon and more slowly. That changes where the fermentation happens rather than whether it does. Slower fermentation is often better tolerated, which is the practical distinction between the two fructan grades.

Resistant starch escapes amylase digestion and is fermented in the colon, with butyrate a prominent product through cross-feeding chains. Lactobacilli produce lactate that other genera convert onward to butyrate, so the pairing works through a community rather than a single organism. This cross-feeding is well described microbiology.

Pectin is a fermentable soluble fibre and a substrate for several colonic genera, raising acetate and propionate output. It also increases luminal viscosity, which slows transit. Both effects change the environment the delivered organisms land in.

Guar galactomannan is fermented in the colon and is one of the better-tolerated soluble fibres, particularly in its partially hydrolysed form. It supplies substrate while adding viscosity. Viscosity is the trade-off: it slows gastric emptying and can affect the timing of other supplements taken with it.

Beta-glucans are fermented by colonic bacteria and contribute to short-chain fatty acid production, though the extent depends on molecular weight and source. Yeast-derived and cereal-derived beta-glucans behave differently in this respect. The substrate relationship is established; the size of the effect on a given strain is not.

This is a yeast, not a bacterium, so it is unaffected by antibacterial agents that would kill a Lactobacillus preparation and it occupies a different niche. Products combine the two for that non-overlap. Because it is a live yeast, it carries its own considerations for people with central venous access or compromised immunity.

Lactobacilli produce lactate, and bifidobacteria and other colonic genera use lactate and acetate as substrates in cross-feeding chains that end in butyrate and propionate. That is why multi-genus products are not simply two organisms in one capsule. Strain identity still governs any specific effect, and effects do not transfer between strains.

Bifidobacteria dominate the infant colon and remain a significant adult genus, and they ferment oligosaccharides that many lactobacilli cannot. Combining genera widens the substrate range covered by a product. The claim that any particular pair works better than either alone requires strain-level evidence, which is not assumed here.

Plantarum strains tolerate a wide pH and salt range and are among the most commonly formulated, and one such strain appears in the candidate literature for this ingredient. Multi-strain products combine complementary tolerances and adhesion profiles. Strain specificity is the hard rule: a result from one plantarum strain does not carry to another.

Acidophilus is acid and bile tolerant, which is the property that got it into the earliest commercial products. It is routinely combined with other lactobacilli and bifidobacteria. What the combination does depends on the specific strains and their documented properties rather than on the species name.

Lactoferrin binds iron tightly, and many gut organisms compete for iron while lactobacilli have unusually low iron requirements. Restricting free iron therefore tilts the competitive balance. This is established microbiology applied to a formulation choice, not a measured clinical effect of the pair.

Bovine colostrum supplies immunoglobulins, lactoferrin and milk oligosaccharides, the last of which are fermentable substrates. It is combined with probiotics in gut-barrier positioning. Support for the specific combination in adults is limited and the row stays on the page.

Glutamine is the preferred fuel of the small intestinal epithelium, and epithelial energy status is one input to barrier integrity. A live organism preparation acts on the luminal side, glutamine on the cell. Different targets, same tissue, and no combination trial in the set available here.

Zinc is a structural and catalytic cofactor across hundreds of enzymes, including those governing rapid epithelial cell turnover, and low zinc status impairs mucosal repair. That makes it complementary to a luminal intervention rather than overlapping with it. Note the separate competition: high zinc doses compete with copper for the same transporter.

The vitamin D receptor is expressed in gut epithelium and in immune cells resident in the mucosa, and calcitriol influences the expression of tight junction and antimicrobial peptide genes. That places it upstream of the environment probiotics act in. The mechanism is well described; combination outcome data is not in this set.

Riboflavin-overproducing lactic acid bacteria have been selected specifically for their ability to raise luminal riboflavin, and riboflavin is also used by other gut organisms as an electron shuttle. The relationship therefore runs in both directions depending on strain. Strain selection decides which direction applies.

Glutamate decarboxylase activity in certain lactic acid bacteria converts glutamate to GABA, and this is well characterised in fermented food microbiology. Whether luminal GABA reaches the central nervous system in meaningful amounts is a separate and unresolved question. The conversion is established, the downstream inference is not.

A randomised trial combined a probiotic with iron and folic acid and reported effects on iron status and gut inflammation markers, which are markers and not clinical outcomes. Mechanistically, unabsorbed iron reaching the colon favours some organisms over lactobacilli, so the direction of the interaction is not obvious in advance. Read the row as a measured marker signal in a specific supplementation setting.

Thiosulfinates from crushed garlic inhibit a wide range of bacteria in laboratory systems, and that activity does not stop neatly at unwanted organisms. Taking a strongly antibacterial botanical in the same swallow as a live culture is worth separating in time. How much this matters at food or supplement doses in the gut is not established.

Catechins reaching the colon are metabolised by gut bacteria and in turn shift community composition, sometimes favouring lactobacilli and bifidobacteria and sometimes suppressing other genera. The interaction is genuinely bidirectional. Calling it a straightforward gain would overstate what the microbiology shows.

Bentonite is an adsorbent with broad, non-selective binding, used precisely because it is indiscriminate. Taken together with a live culture or a fermentable substrate it can bind material the organisms need. Separating adsorbents from everything else by a few hours is standard practice.

Supplemental proteases, amylases and lipases act in the stomach and small intestine, upstream of where colonic organisms work. Reducing the load of undigested substrate reaching the colon can reduce fermentation gas. That means the two are complementary and, at the margins, mutually offsetting on substrate supply.

Slippery elm polysaccharides form a viscous mucilage that coats mucosa and is itself partly fermentable. Both effects touch the environment a live culture lands in. The evidence is traditional use plus polysaccharide chemistry rather than a measured interaction.